Retrocyclin RC-101 Blocks HIV-1 Transmission Across Cervical Mucosa in an Organ Culture

    Authors

    P. Gupta; D. Ratner; M. Ding; B. Patterson; L. C. Rohan; T. A. Reinhart; V. Ayyavoo; X. L. Huang; D. L. Patton; B. Ramratnam;A. M. Cole

    Comments

    Authors: contact us about adding a copy of your work at [email protected]

    Abbreviated Journal Title

    Jaids

    Keywords

    retrocyclin; HIV; organ culture; microbicide; IMMUNODEFICIENCY-VIRUS-INFECTION; FEMALE GENITAL-TRACT; IN-VITRO; TOPICAL MICROBICIDES; CANDIDATE MICROBICIDES; REVERSE-TRANSCRIPTASE; VAGINAL MICROBICIDE; EXPLANT CULTURE; NONOXYNOL-9 USE; T-CELLS; Immunology; Infectious Diseases

    Abstract

    Background: Cervical tissue-based organ cultures have been used successfully to evaluate microbicides for toxicity and antiviral activity. The antimicrobial peptide retrocyclin RC-101 has been shown to have potent anti-HIV activity in cell culture. Objective: To evaluate RC-101 in organ culture for toxicity and its ability to block HIV-1 transmission across cervical mucosa. Methods: A cervical tissue-based organ culture was used to measure antiviral activity of RC-101. Cytotoxicity in tissues was determined by immunostaining of cellular proteins and by measuring inflammatory cytokines using real-time reverse transcriptase-polymerase chain reaction and Luminex technology. Results: RC-101 blocked transmission of both R5 and X4 HIV-1 across cervical mucosa in this organ culture model. Furthermore, film-formulated RC-101 exhibited potent antiviral activity in organ culture. Such antiviral activity of RC-101 was retained in the presence of semen and vaginal fluid. RC-101 showed no cytotoxicity in cervical tissue. Furthermore, RC-101 did not induce proinflammatory cytokine response in tissues. RC-101 also did not have any effect on natural killer cell activity and proliferation of CD4 and CD8 cells and did not show chemotactic activity. Conclusions: Therefore, because of strong antiviral activity and low cytotoxicity in cervical tissues, RC-101 should be considered as an excellent microbicide candidate against HIV-1.

    Journal Title

    Jaids-Journal of Acquired Immune Deficiency Syndromes

    Volume

    60

    Issue/Number

    5

    Publication Date

    1-1-2012

    Document Type

    Article

    Language

    English

    First Page

    455

    Last Page

    461

    WOS Identifier

    WOS:000306994500004

    ISSN

    1525-4135

    Share

    COinS
     

    Accessibility Statement

    This item was created or digitized prior to April 24, 2027, or is a reproduction of legacy media created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the University Libraries provides accessible versions of archival materials upon request. To request an accommodation for this item, please submit an accessibility request form.